| Dr Susanna Leigh Letoto Epp, PSYD | |
|
32650 State Route 20 Ste E203, Oak Harbor, WA 98277-2686 | |
| (360) 682-6499 | |
| Not Available |
| Full Name | Dr Susanna Leigh Letoto Epp |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 13 Years |
| Location | 32650 State Route 20 Ste E203, Oak Harbor, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952607723 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PY60547883 (Washington) | Primary |
| Entity Name | Susanna Leigh L Epp Psyd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922570977 PECOS PAC ID: 1557692175 Enrollment ID: O20191014001268 |
News Archive
A recent study depicted the use of Roche´s Cellavista System to rapidly and effectively carry out a clonal analysis of embryonic stem colony self-renewal in an end-point assay. The Cellavista System proved to be useful for automated mES colony imaging, as well as characterization of colonies as differentiated and undifferentiated based on gating of morphological and intensity criteria. Little or no interference from the feeder cell layers was seen in the analysis of the images.
FerroKin BioSciences, a biotechnology company developing a new therapy for the treatment of iron overload, today announced the closing of a $12 million financing. Participants in the financing include current investors Burrill & Company, Celgene Corporation, Clarus Ventures and MP Healthcare Venture Management, Inc., with Healthcap Ventures of Stockholm participating as a new investor.
Gene therapy that boosts the ability of brain cells to gobble up toxic proteins prevents development of Alzheimer's disease in mice that are predestined to develop it, report researchers at Georgetown University Medical Center. They say the treatment - which is given just once - could potentially do the same in people at the beginning stages of the disease.
New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat the most common – and deadliest – type of brain tumor.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Susanna Leigh Letoto Epp, PSYD 32650 State Route 20 Ste E203, Oak Harbor, WA 98277-2686 Ph: (360) 682-6499 | Dr Susanna Leigh Letoto Epp, PSYD 32650 State Route 20 Ste E203, Oak Harbor, WA 98277-2686 Ph: (360) 682-6499 |
News Archive
A recent study depicted the use of Roche´s Cellavista System to rapidly and effectively carry out a clonal analysis of embryonic stem colony self-renewal in an end-point assay. The Cellavista System proved to be useful for automated mES colony imaging, as well as characterization of colonies as differentiated and undifferentiated based on gating of morphological and intensity criteria. Little or no interference from the feeder cell layers was seen in the analysis of the images.
FerroKin BioSciences, a biotechnology company developing a new therapy for the treatment of iron overload, today announced the closing of a $12 million financing. Participants in the financing include current investors Burrill & Company, Celgene Corporation, Clarus Ventures and MP Healthcare Venture Management, Inc., with Healthcap Ventures of Stockholm participating as a new investor.
Gene therapy that boosts the ability of brain cells to gobble up toxic proteins prevents development of Alzheimer's disease in mice that are predestined to develop it, report researchers at Georgetown University Medical Center. They say the treatment - which is given just once - could potentially do the same in people at the beginning stages of the disease.
New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat the most common – and deadliest – type of brain tumor.
› Verified 6 days ago
Dr. Sarah Anne Sharp, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1370 Sw Fairhaven Dr, Oak Harbor, WA 98277 Phone: 719-352-1635 | |
Mr. Gregory Robert Rolnick, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 840 Se 8th Ave, Suite 204, Oak Harbor, WA 98277 Phone: 360-679-2020 Fax: 360-679-2020 | |
Dr. Steven J. Talmadge, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1360 Sw Fairhaven Dr, Oak Harbor, WA 98277 Phone: 360-679-3310 | |
Dr. Timothy Jon Richter, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1121 Se Dock St, Oak Harbor, WA 98277 Phone: 360-682-6499 | |
Dr. Margaret G Potchatek, PSY. D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 231 Se Barrington Dr, Suite 201, Oak Harbor, WA 98277 Phone: 360-675-9545 | |
Kathryn Marie Westbeld, PHD NCP BCCP LHT Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2126 Black Cat Ln, Oak Harbor, WA 98277 Phone: 602-989-4630 | |
Dr. David Leon Celio, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 520 E Whidbey Ave, Office # 206, Oak Harbor, WA 98277 Phone: 360-675-4027 Fax: 206-329-0866 |